Ventyx Biosciences Inc (VTYX) — Financial Flexibility Index
Ventyx Biosciences Inc (VTYX) has a Financial Flexibility Index of -0.87x as of September 2025. Free cash flow of $-17.46 Million (operating CF $-17.51 Million minus capex $50.00K) represents -1% of total liabilities ($20.10 Million). Check Ventyx Biosciences Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ventyx Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Ventyx Biosciences Inc across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Ventyx Biosciences Inc.
Annual Financial Flexibility Index for Ventyx Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Ventyx Biosciences Inc. Explore how well can Ventyx Biosciences Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.80x | $-130.63 Million | $-130.87 Million | $22.52 Million | ▼ -18.0% |
| 2023 | -4.92x | $-166.01 Million | $-166.52 Million | $33.77 Million | ▲ +12.6% |
| 2022 | -5.63x | $-98.50 Million | $-98.77 Million | $17.50 Million | ▼ -80.0% |
| 2021 | -3.13x | $-38.39 Million | $-38.65 Million | $12.28 Million | ▼ -1527.7% |
| 2020 | -0.19x | $-5.93 Million | $-6.20 Million | $30.90 Million | ▲ +63.9% |
| 2019 | -0.53x | $-2.38 Million | $-2.64 Million | $4.48 Million | — |